Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China

Table 1

The characteristic of 107 participants (54 in metformin group and 53 in repaglinide group) with type 2 diabetes, diagnosed according to World Health Organization criteria.

Parameters	Group metformin			Group repaglinide
	Men	Women	Both	Men	Women	Both
Gender	30	24	54	31	22	53
Mean age	55.4±2.2	57.5±2.4	56.4±1.6	56.9±1.7	59.1±2.1	57.8±1.3
BMI	26.18±0.57	26.11±0.78	26.15±0.46	24.80±0.43	23.96±0.50	24.45±0.33
HbAlc	7.11±0.18	6.76±0.13	6.95±0.12	7.38±0.16	7.48±0.22	7.42±0.13
FPG	7.28±0.23	7.04±0.17	7.17±0.15	7.72±0.20	7.72±0.31	7.72±0.17
FPI	11.36±1.08	12.69±1.81	11.95±1.00	8.17±0.75	8.49±0.73	8.30±0.53
TC	5.38±0.17	5.25±0.18	5.32±0.12	4.98±0.16	5.75±0.23	5.30±0.14
TG	2.11±0.20	1.77±0.15	1.96±0.13	1.97±0.20	2.14±0.26	2.04±0.16
HDL	1.26±0.10	1.28±0.06	1.27±0.06	1.23±0.05	1.51±0.15	1.35±0.07
LDL	3.34±0.13	3.28±0.14	3.32±0.09	3.18±0.16	3.48±0.24	3.30±0.13

Data are shown by means and standard errors. It was only different in TC between men and women of repaglinide group (𝑃<0.05).